Temporary stoma or not for rectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests whether a temporary stoma (a bag on the belly) can be safely avoided in some people having rectal cancer surgery. The goal is to see if it's okay to skip the stoma in those with a low risk of complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with rectal cancer and are scheduled for surgery to remove the tumor and reconnect the bowel (low anterior resection).
- If you are willing to be randomly assigned to a treatment group, you must be under 80 years old and in good overall health (ASA grade I or II).
- Before surgery, you must not have clear signs that the cancer has spread to distant organs (previous surgery for metastases is allowed).
- Your risk of a leak at the bowel connection must be low (score 0 or 1).
- You must be able to understand questionnaires or consent forms in Swedish, Norwegian, Danish, or English.
- You cannot have had previous pelvic radiation, be on high-dose steroids, smoke within 4 weeks of surgery, or have other conditions that increase surgical risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at why some people who had a temporary stoma (a bag for waste) after rectal cancer surgery never get it reversed. It collects information from medical records to find patterns that might explain this.
This study compares a two-stage surgical technique (Turnbull-Cutait pull-through) to standard surgery for people with low rectal cancer. The goal is to see which approach helps more patients avoid a permanent stoma (bag) after surgery.
This trial tests whether using a medication called somatostatin plus a clear liquid diet can safely prevent serious complications after surgery to remove rectal cancer, without needing a temporary opening in the abdomen (stoma). You'll be randomly assigned to receive either somatostatin with diet changes or a stoma, depending on your individual risk factors.
This trial tests a strategy to avoid surgery by using watchful waiting after initial treatment for early-stage rectal cancer. It may help patients keep their rectum and avoid a permanent colostomy.
This trial compares a virtual ileostomy (a system that monitors leaks without creating a temporary opening) to a traditional diverting ileostomy (a temporary bag) in people having rectal cancer surgery. The goal is to see if the virtual method is safer and avoids a second surgery.
This study looks at patterns in the gut microbiome (gut bacteria) and gut chemicals (metabolites) to predict how rectal cancer may do after planned surgery. By understanding these markers, researchers hope to better forecast prognosis and tailor follow-up.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.